Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT03990467
Eligibility Criteria:
Inclusion Criteria:
* Patient ≥ 18 years old
* Patient hospitalized in the critical care department of the Lyon-Sud hospital centre
* Patient with a sepsis or a severe sepsis table defined by the latest international recommendations
* Patient to be treated by the amikacin + piperacillin/tazobactam association
* Patient affiliated to a social security system, having agreed to participate in the study
Exclusion Criteria:
* Patient with a known history of hypersensitivity or contraindication to amikacin, piperacillin or tazobactam
* Patient known to have previously received piperacillin/tazobactam or amikacin combination before inclusion
* Patient treated at the time of inclusion with dialysis techniques
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03990467
Study Brief:
Protocol Section:
NCT03990467